New fill/finish partnership with BioConnection
provides end-to-end drug product development under 1 contract!
Read the press release
About Us
Our Company
Executive Leadership
Locations
Global Facilities Network
Seattle
Boulder
Copenhagen
Heidelberg
Milan
Chiba
Longmont
Our Services
Offerings
Mammalian
Microbial
pDNA
Viral Vectors
Cell Therapy
mRNA
Specialized Platforms & Programs
AGCellerate™
BravoAAV™
ProntoLVV™
Proveo™
CMC Jumpstart™
Services
Tech Transfer
Process Development
Cell Line Development
Analytical & Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fill & Finish
News & Resources
News & Blogs
Press Releases
Biopharma Thought Leadership Blog
Events & Conferences
Resources
Resources & Scientific Content
Fact Sheets
Case Studies
Video Library
Media Kit
Careers
Career Opportunities
Life at a CDMO
Diversity, Equity & Inclusion
Seattle Team
Boulder Team
Copenhagen Team
Heidelberg Team
Milan Team
Chiba Team
Search
Search
Toggle Menu
Search
Search
Toggle Menu
About Us
Toggle Menu
Our Company
Executive Leadership
Locations
Toggle Menu
Global Facilities Network
Seattle
Boulder
Copenhagen
Heidelberg
Milan
Chiba
Longmont
Our Services
Toggle Menu
Offerings
Toggle Menu
Mammalian
Microbial
pDNA
Viral Vectors
Cell Therapy
mRNA
Specialized Platforms & Programs
Toggle Menu
AGCellerate™
BravoAAV™
ProntoLVV™
Proveo™
CMC Jumpstart™
Services
Toggle Menu
Tech Transfer
Process Development
Cell Line Development
Analytical & Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fill & Finish
News & Resources
Toggle Menu
News & Blogs
Toggle Menu
Press Releases
Biopharma Thought Leadership Blog
Events & Conferences
Resources
Toggle Menu
Resources & Scientific Content
Fact Sheets
Case Studies
Video Library
Media Kit
Careers
Toggle Menu
Career Opportunities
Life at a CDMO
Diversity, Equity & Inclusion
Seattle Team
Boulder Team
Copenhagen Team
Heidelberg Team
Milan Team
Chiba Team
Our Company
About Us
Our History
Mission & Values
Executive Leadership
Locations
Global Facilities Network
Seattle
Boulder
Copenhagen
Heidelberg
Milan
Chiba
Yokohama
Longmont
Policies
Environment, Health & Safety
Group Privacy Policies
Offerings
Mammalian
Microbial
pDNA
Viral Vectors
Cell Therapy
mRNA
Services
Tech Transfer
Process Development
Cell Line Development
Analytical & Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fill & Finish Services
Specialized Platforms & Programs
AGCellerate™ mAb & LVV Programs
ProntoLVV™ Lentiviral Vector Platform
BravoAAV™ Adeno-Associated Vector Platform
Proveo™ ADC Program
CMC Jumpstart™ Program
News & Blogs
Press Releases
Biopharma Thought Leadership Blog
Events & Conferences
Resources
Research & Scientific Content
Fact Sheets
Case Studies
Video Library
Media Kit
Fact Sheet Quick Links
Global cGMP Manufacturing (PDF)
CHEF1
TM
Expression Technology (PDF)
Mammalian Capabilities (PDF)
Microbial Capabilities (PDF)
Cell Therapy Capabilities (PDF)
Viral Vector Capabilities (PDF)
Plasmid DNA Capabilities (PDF)
Messenger RNA Capabilities (PDF)
Join Us
Career Opportunities
What Drives Us
Life at a CDMO
Diversity, Equity and Inclusion
Meet Our Teams
Seattle
Boulder
Copenhagen
Heidelberg
Milan
Chiba
AGC Biologics
1 min read
AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings
June 1, 2020 at 3:00 PM
Press Release
Read press release
2 min read
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)
May 20, 2020 at 11:00 PM
Press Release
Read press release
AGC Biologics Manufactures Key Ingredient in Potential COVID-19 Treatment Drug, Leronlimab
April 29, 2020 at 3:49 PM
Press Release
Read press release
2 min read
AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine
April 24, 2020 at 5:00 AM
Press Release
Read press release
AGC Biologics in the news for our work toward COVID-19 treatment
April 6, 2020 at 7:37 AM
Press Release
Read press release
2 min read
AGC Inc. Decides to Launch Voluntary Tender Offer for Shares of Molmed
March 17, 2020 at 9:54 AM
Press Release
Read press release
AGC Biologics Plasmid Production
March 16, 2020 at 1:58 PM
Press Release
Read press release
2 min read
Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases
February 7, 2020 at 1:38 PM
Press Release
Read press release
2 min read
AGC Biologics Expands Plasmid DNA Offering
December 11, 2019 at 1:42 PM
Press Release
Read press release
Prev
1
2
3
